Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
INTRODUCTION: Although HAART has led to a reduction in overall mortality among HIV-infected individuals, its impact on death from specific causes is unknown. METHODS: Twenty-two cohorts of HIV-infected individuals with known dates of seroconversion are pooled in the CASCADE collaboration. Causes of...
Main Authors: | Smit, C, Geskus, R, Walker, S, Sabin, C, Coutinho, R, Porter, K, Prins, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion.
by: Thiébaut, R, et al.
Published: (2006) -
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
by: Bhaskaran, K, et al.
Published: (2004) -
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
by: Porter, K, et al.
Published: (2003) -
Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.
by: Babiker, A, et al.
Published: (2003) -
Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort
by: Van Santen, D, et al.
Published: (2019)